These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31424296)

  • 1. Multidrug resistance in
    Boyanova L; Hadzhiyski P; Kandilarov N; Markovska R; Mitov I
    Expert Rev Clin Pharmacol; 2019 Sep; 12(9):909-915. PubMed ID: 31424296
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in the pharmacological and regulatory management of multidrug resistant
    Rokkas T; Ekmektzoglou K
    Expert Rev Clin Pharmacol; 2023; 16(12):1229-1237. PubMed ID: 37937850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifunctional Enzyme SpoT Is Involved in Biofilm Formation of Helicobacter pylori with Multidrug Resistance by Upregulating Efflux Pump Hp1174 (
    Ge X; Cai Y; Chen Z; Gao S; Geng X; Li Y; Li Y; Jia J; Sun Y
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
    Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
    Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of biofilm formation by clinical isolates of
    Attaran B; Falsafi T; Ghorbanmehr N
    World J Gastroenterol; 2017 Feb; 23(7):1163-1170. PubMed ID: 28275296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line rescue treatment of
    Lin TF; Hsu PI
    World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future insights in H. pylori eradication regimens: the need of tailoring therapy.
    Papastergiou V; Georgopoulos SD; Karatapanis S
    Curr Pharm Des; 2014; 20(28):4521-32. PubMed ID: 24180408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of multiple drug-resistant Helicobacter pylori strains among patients with different gastric disorders in Iran.
    Shokrzadeh L; Alebouyeh M; Mirzaei T; Farzi N; Zali MR
    Microb Drug Resist; 2015 Feb; 21(1):105-10. PubMed ID: 25303151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance in Helicobacter pylori: current situation and management strategy in Vietnam.
    Phan TN; Tran VH; Tran TN; Le VA; Santona A; Rubino S; Paglietti B
    J Infect Dev Ctries; 2015 Jul; 9(6):609-13. PubMed ID: 26142670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection.
    Lim JH; Lee DH; Lee ST; Kim N; Park YS; Shin CM; Song IS
    World J Gastroenterol; 2015 Dec; 21(46):13124-31. PubMed ID: 26673999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study.
    Zhang YX; Zhou LY; Song ZQ; Zhang JZ; He LH; Ding Y
    World J Gastroenterol; 2015 Mar; 21(9):2786-92. PubMed ID: 25759550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility of Helicobacter pylori in Iceland.
    Gunnarsdottir AI; Gudjonsson H; Hardardottir H; Jonsdottir KD; Bjornsson ES
    Infect Dis (Lond); 2017 Sep; 49(9):647-654. PubMed ID: 28440099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Helicobacter pylori infection: Where are we now?
    Liou JM; Wu MS; Lin JT
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1918-1926. PubMed ID: 27088632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Helicobacter pylori-associated diseases].
    Gisbert JP
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():39-48. PubMed ID: 26520195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect and mechanism of Qingre Huashi decoction on drug-resistant
    Lin MM; Yang SS; Huang QY; Cui GH; Jia XF; Yang Y; Shi ZM; Ye H; Zhang XZ
    World J Gastroenterol; 2024 Jun; 30(24):3086-3105. PubMed ID: 38983958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux.
    Cai Y; Wang C; Chen Z; Xu Z; Li H; Li W; Sun Y
    Helicobacter; 2020 Aug; 25(4):e12715. PubMed ID: 32548895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current options for the treatment of Helicobacter pylori.
    Georgopoulos SD; Papastergiou V; Karatapanis S
    Expert Opin Pharmacother; 2013 Feb; 14(2):211-23. PubMed ID: 23331077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic-resistant Helicobacter pylori strains in Portuguese children.
    Lopes AI; Oleastro M; Palha A; Fernandes A; Monteiro L
    Pediatr Infect Dis J; 2005 May; 24(5):404-9. PubMed ID: 15876938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe.
    Di Ciaula A; Scaccianoce G; Venerito M; Zullo A; Bonfrate L; Rokkas T; Portincasa P
    J Gastrointestin Liver Dis; 2017 Jun; 26(2):129-137. PubMed ID: 28617882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.